motif Launches Clarity, a First-of-Its-Kind AI Financial Intelligence System
19.5.2026 12:39:00 CEST | Business Wire | Press Release
motif, the AI wealth advisory company backed by Liminal (a venture creation group founded by Temasek), today launched Clarity, an AI financial intelligence system that tracks how markets, assets and financial relationships connect, and how and why they change over time, building enriched connections that deliver the kind of structured, sourced insight that financial institutions have never had, even with dedicated analyst teams.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511241653/en/
motif Launches Clarity, a First-of-Its-Kind AI Financial Intelligence System
Financial institutions integrate Clarity into their products so customers can make better-informed investment decisions, while analysts and product teams use it to track market shifts and plan accordingly. Informed investors engage more and stay longer, and for the institutions serving them, that engagement translates directly into retention and profitability.
Multiple financial institutions have contracts ahead of launch, collectively representing over 1.5 million end users and billions in assets under management.
The Technology Behind Clarity
Clarity only ingests verified, high-quality sources, from analyst research and regulatory filings to earnings reports and macro data. What goes in matters as much as what comes out. It treats every relationship as a first-class object with structured metadata: how it was established, current and previous states, which sources support it, confidence levels, and when it was last verified. When new information arrives, Clarity records both old and new states along with the cause of the change.
No AI product has combined these capabilities into a single architecture with full lifecycle tracking.
How Institutions Use Clarity
Clarity powers AI advisory agents delivered as a modular API and SDK. Institutions plug it into existing products, choose the agents they need, configure tone and language to match their brand, and deploy in days.
“AI products in financial services are wrappers around language models connected to data feeds. They retrieve information, they don’t understand it. That doesn’t work. Hallucinations, inconsistency, zero understanding. So we rebuilt from the ground up,” said Mario Leoni, co-founder and CEO of motif.
About motif
motif is an AI wealth advisory company headquartered in Zug, Switzerland. Founded in December 2024 by Mario Leoni and Andras Hejj, motif equips financial institutions with agent-powered advisory they integrate into their own products. For more information, visit chatwithmotif.com or contact mario@chatwithmotif.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260511241653/en/
Contacts
Mario Leoni, CEO | mario@motifapp.ai
Media Pack: https://bit.ly/clarity_rls -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbit.ly%2Fclari
ty_rls&esheet=54533221&newsitemid=20260511241653&lan=en-US&anchor=https%3A%2F%2F
bit.ly%2Fclarity_rls&index=2&md5=2db198685d490c87a074408a485ca589
Web: chatwithmotif.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fchatwithmotif.
com&esheet=54533221&newsitemid=20260511241653&lan=en-US&anchor=chatwithmotif.com
&index=3&md5=4b1cafdf0e1fad232ae153fd43d5ad6f
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on ALYFTREK ® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating the long-term safety and efficacy profile of the medicine. The data, presented at the European Cystic Fibrosis Conference, show children ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including those who are homozygous for the F508del mutation (F/F) and those who have F508del/minimal function mutations (F/MF)on ALYFTREK had further improvement in CFTR function from a TRIKAFTA ® baseline as measured by sweat chloride (SwCl), with 65% having achieved SwCl <30 mmol/L after treatment with ALYFTREK. Vertex also presented Phase 3 data of children ages 1 to <2 with TRIKAF
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press Release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press Release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press Release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press Release
A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal opportunities across the Group’s production sites and communities. These are just some of the “sustainability” stories the Barilla Group is sharing on World Environment Day with the publication of its 2025 Sustainability Report. The report comes just after Barilla was named the world’s most reputable company in the food sector for the third year running and, for the first time, ranked among the global top 10 in the Global RepTrak 100 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603162436/en/ “The future of the planet will increasingly depend on our ability to spread culture and education,” says Paolo Barilla, Vic
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom